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alreticulin (
 
crt
 
) is an ubiquitously expressed and
 
multifunctional Ca
 
2
 
 
 
-binding protein that regulates
diverse vital cell functions, including Ca
 
2
 
 
 
 storage
in the ER and protein folding. Calreticulin deﬁciency in
mice is lethal in utero due to defects in heart development
 
and function. Herein, we used 
 
crt
 
 
 
/
 
 
 
 embryonic stem (ES)
cells differentiated in vitro into cardiac cells to investigate
the molecular mechanisms underlying heart failure of
knockout embryos. After 8 d of differentiation, beating areas
were prominent in ES-derived wild-type (wt) embryoid bodies
 
(EBs), but not in ES-derived 
 
crt
 
 
 
/
 
 
 
 EBs, despite normal
expression levels of cardiac transcription factors. 
 
Crt
 
 
 
/
 
 
 
EBs exhibited a severe decrease in expression and a lack
of phosphorylation of ventricular myosin light chain 2
(MLC2v), resulting in an impaired organization of myo-
C
 
ﬁbrils. C
 
rt
 
 
 
/
 
 
 
 phenotype could be recreated in wt cells
 
by chelating extracellular or cytoplasmic Ca
 
2
 
 
 
 with EGTA
or BAPTA, or by inhibiting Ca
 
2
 
 
 
/calmodulin-dependent
kinases (CaMKs). An imposed ionomycin-triggered cystolic-
free Ca
 
2
 
 
 
 concentration ([Ca
 
2
 
 
 
]
 
c
 
) elevation restored the
expression, phosphorylation, and insertion of MLC2v
into sarcomeric structures and in turn the myoﬁbrillogenesis.
 
The transcription factor myocyte enhancer factor C2
 
failed to accumulate into nuclei of 
 
crt
 
 
 
/
 
 
 
 cardiac cells in
the absence of ionomycin-triggered [Ca
 
2
 
 
 
]
 
c
 
 increase. We
conclude that the absence of calreticulin interferes with
myoﬁbril formation. Most importantly, calreticulin deﬁciency
revealed the importance of a Ca
 
2
 
 
 
-dependent checkpoint
critical for early events during cardiac myoﬁbrillogenesis.
 
Introduction
 
Cardiogenesis is one of the earliest processes during vertebrate
embryogenesis (Olson and Srivastava, 1996; Lin et al.,
1997b; Black and Olson, 1998; Charron and Nemer, 1999;
Harvey, 1999; Harvey and Rosental, 1999; Schwartz and
Olson, 1999; Frey et al., 2000; Srivastava and Olson, 2000).
Although intracellular Ca
 
2
 
 
 
 is a critical second messenger in
the heart, regulating diverse functions from gene expression
to cell contraction and relaxation (Pozzan et al., 1994;
Clapham, 1995), the potential contribution of Ca
 
2
 
 
 
 signal-
ing during early stages of cardiac development remains
largely unexplored.
Within the ER, the Ca
 
2
 
 
 
 reservoir of nonmuscle cells,
Ca
 
2
 
 
 
 is mainly bound to calreticulin (Michalak et al., 1999).
Calreticulin is a highly conserved, 46-kD protein that
modulates many cellular functions, including Ca
 
2
 
 
 
 homeo-
stasis (Liu et al., 1994; Bastianutto et al., 1995; Camacho
and Lechleiter, 1995; Mery et al., 1996; Coppolino et al.,
1997; Fasolato et al., 1998; John et al., 1998), protein folding
(Helenius et al., 1997; Krause and Michalak, 1997; Ellgaard
and Helenius, 2001), integrin-dependent cell adherence
(Coppolino et al., 1995; Opas et al., 1996; Coppolino et al.,
1997), and steroid-dependent gene expression (Burns et al.,
1994; Dedhar et al., 1994).
Calreticulin is essential for proper cardiac development
because knockout of the calreticulin gene is embryonically
lethal due to impaired cardiac development (Mesaeli et al.,
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1999; Rauch et al., 2000). Calreticulin-null mouse embryos
show a marked decrease in ventricular wall thickness and
deep intertrabecular recesses in the ventricular walls (Mesaeli
et al., 1999). Importantly, at early stages of cardiac develop-
ment, calreticulin is highly expressed in differentiating car-
diomyocytes (Mesaeli et al., 1999). It is subsequently down-
regulated in the mature heart (Mesaeli et al., 1999) because
elevated expression of calreticulin in newborn hearts of
transgenic mice leads to complete heart block and sudden
death (Nakamura et al., 2001a).
Mechanisms responsible for impaired cardiac develop-
ment in calreticulin-deficient (
 
crt
 
   
 
) mice are not well un-
derstood. Here we used calreticulin-deficient 
 
crt
 
   
 
 embry-
onic stem (ES)* cells to investigate the role of the protein in
early events of cardiac differentiation.
We show that calreticulin-deficient cardiomyocytes derived
from ES cells had an impaired myofibrillogenesis due to de-
creased ventricular myosin light chain 2 (MLC2v) expression
and phosphorylation. Nuclear translocation of myocyte en-
 
hancer factor C2 (MEF2C), a transcription factor responsible
for activation of several cardiac specific embryonic genes, in-
cluding the MLC2v, was inhibited in 
 
crt
 
 
 
/
 
 
 
 cardiomyocytes.
Furthermore, calreticulin-deficient myocytes featured disorga-
nized myofilaments and inhibited contractile activity. Most
importantly, this phenotype was reversed by transient eleva-
tion of cystolic-free calcium ([Ca
 
2
 
 
 
]
 
c
 
) with a Ca
 
2
 
 
 
 ionophore.
This reveals a Ca
 
2
 
 
 
-dependent checkpoint in early events as-
sociated with cardiac myofibrillogenesis.
 
Results
 
Phenotype of calreticulin-deficient embryoid bodies
 
Fig. 1 shows that 
 
crt
 
 
 
/
 
 
 
 embryoid bodies (EBs) cultured in
suspension between day 2 (D2) and D6 had a significantly
larger size than wild-type (wt) EBs (669 
 
  
 
60 
 
 
 
m, vs. 359 
 
 
 
26 
 
 
 
m, respectively), as measured at D6 (Fig. 1 A, left). De-
spite the size difference, both cell types had similar protein
content as measured for 20 pooled EBs (4.66 
 
  
 
0.55 and
4.82 
 
  
 
1.06 
 
 
 
g/
 
 
 
l in wt and 
 
crt
 
 
 
/
 
 
 
 EBs, respectively; 
 
n
 
 
 
  
 
3;
Fig. 1 A, right). In addition, no difference in the growing ca-
pacity (mitotic rate) of cultured wt versus 
 
crt
 
 
 
/
 
 
 
 undifferen-
tiated ES cells was observed (unpublished data).
Removal of leukemia inhibitory factor (LIF) from the cul-
ture medium induces ES cell differentiation (Maltsev et al.,
 
*Abbreviations used in this paper: [Ca
 
2
 
 
 
]
 
c
 
, cystolic-free Ca
 
2
 
 
 
 concentration;
CaMK, Ca
 
2
 
 
 
/calmodulin-dependent kinase; 
 
crt
 
, calreticulin; EB, embryoid
body; ES, embryonic stem; LIF, leukemia inhibitory factor; MEF, mouse
embryonic fibroblast; MEF2C, myocyte enhancer factor C2; MLC2a,
atrial myosin light chain 2; MLC2v, ventricular myosin light chain 2;
MLCK, myosin light chain kinase; wt, wild-type.
Figure 1. Phenotype of wt or crt
 /  
embryoid bodies (EBs). (A) (Left) Phase-
contrast micrographs showing the 
macroscopic morphology of EBs derived 
from wt (top) or crt
 /  (bottom) ES cells 
at D6 of culture. Bar, 100  m. (Right) EB 
diameter and protein content of wt or 
crt
 /  EB at D6 of culture. (B) Contractility: 
beating activity of EBs at D8 of culture. 
(C) Recording of oscillations in the 
[Ca
2 ]c in wt (left) and crt
 /  EBs (right). 
8-d-old EBs were loaded with Fluo3 and 
[Ca
2 ]c measured in a group of contracting 
cardiomyocytes. The line scan images 
represent changes in Fluo3 fluorescence 
along a line crossing a cardiomyocyte 
(arrows). 
 
 
Calreticulin and Ca
 
2
 
 
 
 in cardiogenesis |
 
 Li et al. 105
 
1994) into EBs containing clusters of contracting cardio-
blasts after 7 d of culture (Meyer et al., 2000). Therefore, we
analyzed for the presence of the contractile activity and the
beating frequency of cardiomyocytes derived from wt and
 
crt
 
 
 
/
 
 
 
 ES cells at D8 of culture. Approximately 70% of the
adherent wt EBs were strongly contracting and contained
more than two beating areas, each beating with a frequency
of 72 
 
  
 
8 contractions/min. In contrast, 90% of 
 
crt
 
 
 
/
 
 
 
 EBs
did not feature any contracting foci (Fig. 1 B). Wild-type
EBs loaded with the Ca
 
2
 
 
 
-indicator dye fluo3 exhibited nor-
mal [Ca
 
2
 
 
 
]
 
c
 
 oscillations (Fig. 1 C, left) (Bony et al., 2001),
whereas 
 
crt
 
 
 
/
 
 
 
 EBs did not show any measurable [Ca
 
2
 
 
 
]
 
c
 
spikes (Fig. 1 C, right).
The myofibrillogenesis was evaluated in 8-d-old EBs by in
situ immunostaining of sarcomeric proteins 
 
 
 
-actinin and
MLC2v. As expected (Meyer et al., 2000), in wt ES-derived
cardiomyocytes, 
 
 
 
-actinin and MLC2v appeared organized
as an interconnected network with the myofibrils stretching
throughout the cytoplasm even by running from one cell into
another (Fig. 2 A, a and b). These newly formed sarcomeres
featured a length of 2 
 
 
 
m, similar to that of adult cardiac sar-
comeres, indicating that the contractile apparatus was fully
organized at this stage of EBs development. In contrast, 
 
crt
 
 
 
/
 
 
 
cardiomyocytes showed an anomalous distribution of both
 
 
 
-actinin and MLC2v (Fig. 2 A, c and d).  -actinin was not
incorporated into the Z-disks but remained localized in cyto-
solic spots. MLC2v also failed to form and localize to the A
bands. It was distributed within the cytosol as short disorga-
nized filaments. In addition, a severe reduction in MLC2v
mRNA and protein was also observed as revealed by reverse
transcription–PCR (unpublished data) and Western blot
analysis (Fig. 2 B), respectively. This indicated that calreticu-
lin deficiency interferes with myofibril formation.
Effect of extracellular Ca
2  chelation, intracellular 
[Ca
2 ]c buffering, and inhibition of calmodulin-
dependent protein kinases on ES cell differentiation
Calreticulin-deficient mouse embryonic fibroblasts (MEFs)
have impaired Ca
2  release from ER (Nakamura et al.,
2001b). To test whether an altered Ca
2  homeostasis in cal-
Figure 2. Myofibrillogenesis in 
cardiomyocytes within EBs at D8 of 
differentiation. (A) Distribution of 
 -actinin and MLC2v in control (a and b) 
and crt
 /  cardiomyocytes (c and d). 
Proteins were visualized by staining 
with a mouse monoclonal anti– -actinin 
antibody and a rabbit anti-MLC2v 
antiserum followed by a secondary anti–
mouse FITC- or anti–rabbit Rhodamine-
conjugated IgG, respectively. Each image 
was analyzed by digital deconvolution 
of 25–35 successive optical Z-sections 
(acquired with Metamorph software), 
and visualized as shadow projections of 
three-dimensional reconstructions (Imaris 
software). This figure is representative of 
five independent experiments. Bars, 10 
 m. (B) MLC2v protein expression 
during the differentiation of wt or crt
 /  
EBs. Proteins extracted from EBs were 
separated by SDS-PAGE and transferred 
to a PDVF membrane. The blot was 
probed with a rabbit anti-MLC2v 
antiserum. The arrowheads indicate the 
location of MLC2v band.106 The Journal of Cell Biology | Volume 158, Number 1, 2002
reticulin-deficient cardiomyocytes was responsible for an ab-
normal myofibrillogenesis and impaired contractility, we
modulated extracellular or intracellular [Ca
2 ]c. Starting at
D4 of differentiation, we either removed extracellular Ca
2 
from the medium with EGTA (2 mM) or chelated [Ca
2 ]c
with BAPTA/AM (25  M) during differentiation of wt
EBs. D4 was chosen because at this time, although cardiac
transcription factors are fully detectable by reverse transcrip-
tion–PCR, no genes encoding constitutive cardiac proteins
are yet expressed. Removal of extracellular Ca
2  or chelation
of [Ca
2 ]c led to a dramatic reduction in beating wt EBs ob-
served at D8 (Fig. 3 A), and impaired myofibrillogenesis
reminiscent of the calreticulin-deficient phenotype of EBs
(Fig 2). Concomitantly, there was a reduction of MLC2v
protein (Fig. 3 B).
The activation of Ca
2 /calmodulin-dependent protein ki-
nases (CaMKs) is essential for myofibrillogenesis (Zhang et
al., 2002) and sarcomere organization (Aoki et al., 2000). To
test the involvement of CaMKs in EGTA or BAPTA-depen-
dent inhibition of myofibrillogenesis we used KN93, an in-
hibitor of CaMKII (Sumi et al., 1991). wt EBs treated with
KN93 from D4 to D8 had impaired distribution of both
 -actinin and MLC2v, similar to the EGTA- or BAPTA-
treated cells. Most importantly, they exhibited a phenotype
similar to crt
 /  cardiomyocytes. MLC2v was spread within
the cytosol as short disorganized filaments (Fig. 3 C, d, f,
and h vs. b for control), whereas  -actinin showed a spotted
distribution (Fig. 3 C, c, e, and g). We concluded that eleva-
tion of [Ca
2 ] and activation of CaMK are essential for early
stages of myofibrillogenesis, and that these processes are im-
paired in the absence of calreticulin.
Ca
2 -dependent rescue of the myofibrillogenesis in 
calreticulin-deficient cardiomyocytes
The phenotype of wt cells differentiated in the absence of
extracellular Ca
2  or under Ca
2  buffering conditions was
reminiscent of the phenotype of crt
 /  cells. Therefore, we
tested whether a transient elevation of [Ca
2 ]c prior to myo-
fibrillogenesis (i.e., appearance of recognizable cardiac cells)
would initiate myofibril formation and restore the beating
activity in the calreticulin-deficient EBs.
To elicit a transient increase in [Ca
2 ]c, we incubated crt
 / 
EBs at D4 with the Ca
2  ionophore ionomycin (10–1,000
nM) for 2 h, as indicated in Fig. 4 A. Only a 2-h treatment
(followed by a washout) was used to exclude any potential
toxic effect of ionomycin. Western blot analysis revealed no
Figure 3. Effect of extracellular Ca
2  chelation, [Ca
2 ]c buffering, 
or inhibition of CaMKs on differentiation of cardiomyocytes within 
EBs. (A) The presence of contracting foci within EBs at D8 of culture was evaluated after daily treatment of wt EBs starting at D4 of culture 
with: (1) untreated EBs; (2) DMSO (control solvent used for BAPTA and KN93); (3) 2 mM EGTA to buffer extracellular Ca
2 ; (4) 25  M 
BAPTA/AM to buffer [Ca
2 ]c; (5) 10  M KN92; and (6) 10  M KN93. (B) Effect of Ca
2  chelation and/or buffering protocols on the MLC2v 
expression in wt or crt
 /  EBs, as analyzed by Western blot with the anti-MLC2v antiserum (IH treatment). (C) Immunolocalization of  -actinin 
(left) and MLC2v (rights) in EGTA- (2 mM) or BAPTA/AM-treated cells (25  M). Shadow projections of three-dimensional reconstructions 
were generated as described in Fig. 2. Bars, 10  m. Calreticulin and Ca
2  in cardiogenesis | Li et al. 107
significant change in the level of GRP94, a heat-shock ER
chaperone of the HSP90 family normally upregulated after
prolonged exposure to increased intracellular Ca
2  (Mitani
et al., 1996) (unpublished data). This confirmed that this
exposure of crt
 /  cells to Ca
2  ionophore did not induce
notable cell stress. Furthermore, we did not detect any cell
death after ionomycin treatment, as determined by cell via-
bility using trypan blue exclusion (3.8   0.2% positive cells
in control EBs vs. 3.4   0.3% in ionomycin-treated EBs)
and by extracellular release of cytosolic lactate dehydroge-
nase (1.5   0.1% from control EBs vs. 2.0   0.2% from
ionomycin-treated EBs; n   3).
Fig. 4 B shows that addition of 100 nM ionomycin to wt and
crt
 /  EBs induced a transient elevation in [Ca
2 ]c in both types
of EBs. After washout, [Ca
2 ] returned to basal level within 5 h.
Crt
 /  ES-derived EBs were incubated with 10–100 nM
ionomycin, at D4 (Fig. 4, C and D) or D7 (Fig. 4 D), fol-
lowed by washout and analysis of their beating activity 4 d
after addition of the ionophore. Fig. 4 C shows that crt
 / 
EBs treated with ionomycin had fully restored beating activ-
ity as rapidly as 4 d after ionomycin treatment. Partial recov-
ery of EBs (20% beating EBs) was already observed the first
day after incubation with ionomycin (unpublished data).
Next, we tested MLC2v expression in crt
 /  cardiomyo-
cytes within ionomycin-treated EBs. There was a correct in-
sertion of both  -actinin and MLC2v into sarcomeric struc-
tures (Fig. 5 A), indicating that myofibrillogenesis was
restored in crt
 /  cells as a result of ionomycin treatment.
Importantly, crt
 /  EBs treated with ionomycin expressed
high levels of MLC2v protein as observed for wt (Fig. 5 B).
Phosphorylation of MLC2v by the Ca
2 /calmodulin-
dependent myosin light chain kinase (MLCK) is a prerequi-
site for its insertion into the A-band of the sarcomere (Sanbe
et al., 1999). The phosphorylated and unphosphorylated
forms of MLC2v can be readily identified by two-dimen-
sional gel electrophoresis and followed by Western blot
Figure 4. Rescue of the contractile 
ability and the myofibrillogenesis in crt
 /  
cells by Ca
2  ionophore. (A) Protocol of 
ionomycin treatment of EBs in the 
course of differentiation. (B) Effect of 
ionomycin on intracellular Ca
2  of 
fluo4-loaded wt or crt
 /  EBs at D4. 
Fluo4-loaded EBs were cultured in a 
miniculture chamber on the stage of the 
microscope and challenged with 100 
nM ionomycin for 2 h. After fluo4 
reloading, ionomycin was washed out 
and Ca
2  measured for 10–15 h using 
the time-lapse mode of Metamorph (one 
measurement/30 min). (C) Dose–response 
increase of the contractile activity in crt
 /  
EBs treated with different concentrations 
of ionomycin. (D) Effect of 2 h treatment 
with ionomycin applied at D4 or D7 on 
beating activity of crt
 /  EBs measured at 
D8, or D11, respectively.108 The Journal of Cell Biology | Volume 158, Number 1, 2002
analysis with specific antibodies. As expected, wt EBs con-
tained both phosphorylated and unphosphorylated forms of
MLC2v. In contrast, in crt
 /  cardiomyocytes, there was no
detectable phosphorylated MLC2v (Fig. 5 C, middle). Most
importantly, treatment of crt
 /  EBs with ionomycin re-
sulted in appearance of phosphorylated MLC2v (Fig. 5 C,
bottom). This indicated that crt
 /  cardiomyocytes feature
impaired Ca
2 -dependent phosphorylation of MLC2v.
Interestingly, the content of atrial MLC2 (MLC2a) was not
significantly affected by treating wt or crt
 /  EBs with iono-
mycin (Fig. 5 D), and it was correctly inserted into sarcomeres
in crt
 /  cardiomyocytes (Fig. 5 E). We concluded that crt
 / 
EBs are deficient in a specific Ca
2  signal (“checkpoint”) re-
quired for elevated expression of MLC2v (but not MLC2a),
its phosphorylation, and assembly into functional sarcomeres.
Nuclear translocation of MEF2C is impaired in 
calreticulin-deficient cardiomyocytes
To investigate mechanisms responsible for downregulation of
MLC2v in the absence of calreticulin, we measured expression
and nuclear targeting of MEF2C, GATA4, and Nkx2.5, a
group of cardiac transcription factors known to regulate the
MLC2v gene expression. MEF2C, GATA4, and Nkx2.5 are
detected as early as D4 to D5 of EB culture (Meyer et al.,
2000). Real-time quantitative PCR analysis revealed no differ-
ences in the expression of all three transcription factors at D8 in
wt and crt
 /  EBs (Fig. 6 A). Ionomycin treatment had no sig-
nificant effect on expression of MEF2C, GATA4, and Nkx2.5
in wt cells (Fig. 6 A); however, Western blot analysis revealed an
increase in MEF2C levels in ionomycin-treated crt
 /  EBs (Fig.
6 B). In contrast, GATA4 and NKx2.5 mRNA were decreased
to 40 and 50%, respectively, in ionomycin-treated crt
 /  EBs
(Fig. 6 A). The increased level of MEF2C in ionomycin-treated
cells was observed at the protein level in both wt and crt
 /  EBs,
whereas we did not detect any significant difference of MEF2C
content in wt versus crt
 /  under control conditions (Fig. 6 B).
Next, we investigated the localization of MEF2C, which
regulates the activity of MLC2v promoter (Zou and Chien,
1995). Fig. 7 illustrates the intranuclear distribution of
MEF2C within EBs. Distribution of nuclei within EBs was
identified by Hoechst staining (Fig. 7, inset). In wt EBs, nuclei
were strongly stained by the anti-MEF2C antibody, as visual-
ized by the intranuclear three-dimensional distribution of
MEF2C using the shadow projection mode (Fig. 7 A, a), as
Figure 5. MLC2v and myofibrillogenesis in ionophore-treated EBs. 
(A) Reestablishment of the myofibrillogenesis in ionomycin-treated 
EBs.  -actinin (left) and MLC2v distribution (right), visualized as 
shadow projection after three-dimensional reconstruction of z-series 
images. Bars, 10  m. (B) Control and ionomycin-induced increase 
of MLC2v expression during EB differentiation, as analyzed by 
Western blot with the anti-MLC2v antibodies. (C) Two-dimensional 
gel electrophoresis of wt and crt
 /  detergent-insoluble contractile 
proteins. The phosphorylated (MLC2v-P) and unphosphorylated 
forms of MLC2v (arrows) were identified by Western blot analysis 
using the anti-MLC2v antiserum. (D) Effect of ionomycin treatment 
on MLC2a expression in wt and crt
 /  EBs, as assessed by Western 
blot analysis with the anti-MLC2a antibodies. (E) Immunolocalization 
of MLC2a in crt
 /  EBs, visualized as shadow projection after three-
dimensional reconstruction of z-series images. Bar, 10  m. Calreticulin and Ca
2  in cardiogenesis | Li et al. 109
well as by the summed fluorescence across the nuclei (Fig. 7 A,
a ). In contrast, MEF2C failed to accumulate within the nuclei
of crt
 /  EBs and remained perinuclear (Fig. 7 A, b–b ). Im-
portantly, the ionomycin-induced [Ca
2 ]c elevation resulted in
the restoration of MEF2C translocation into nuclei of crt
 / 
EBs (Fig. 7 A, d–d ), as well as in an increased accumulation of
MEF2C into nuclei of wt cells (Fig. 7 A, c–c ). The impaired
nuclear transport was specific to MEF2C because the intracel-
lular distribution of another cardiac transcription factor,
GATA4, was not affected. Fig. 7 C shows that GATA4 was lo-
calized to the nuclei in both wt and crt
 /  cells, indicating that
the nuclear import of this transcription factor was not affected
by the absence of calreticulin. This indicates that Ca
2 -depen-
dent processes are involved in the specific translocation of
MEF2C to the nucleus of wt and crt
 /  cells.
Next, we tested for a role of CaMKs in nuclear transloca-
tion of MEF2C. wt EBs were treated with KN93 from D4 to
D8 to inhibit CaMK. In KN93-treated EBs, MEF2C was not
targeted into the nucleus, resulting in the absence of contrac-
tile foci in these 8-d-old EBs (unpublished data; Fig. 3 A).
KN92 was used as a negative control, and as expected, it did
not affect MEF2C nuclear targeting or EB contractility.
Discussion
The generation of mice deficient in calreticulin has uncovered
a critical role of the ER Ca
2 -binding protein (Mesaeli et al.,
1999). Calreticulin-deficient mice display defects in heart de-
velopment and function due to reduced thickness of the ven-
tricular wall and impaired trabeculation (Mesaeli et al., 1999).
Here we used calreticulin-deficient ES cells to investigate the
molecular mechanisms responsible for the heart failure of crt
 / 
mice. We demonstrated that during the differentiation pro-
cess, crt
 /  ES-derived cardiomyocytes feature a severe disrup-
tion of myofibrillogenesis due to insufficient expression and
Ca
2 -dependent phosphorylation of MLC2v. This is likely
due to insufficient availability and mobilization of Ca
2  from
ER in crt
 /  cells as manifested by inhibited CaMK-depen-
dent nuclear translocation of MEF2C. The importance of
Ca
2  in these processes is documented by rescue of crt
 /  phe-
notype with Ca
2  ionophore. We show that differentiation
proceeds normally at the very early stages of crt
 /  EBs forma-
tion, but that they fail to undergo normal myofibril formation
in the absence of calreticulin and a specific ER-dependent
Ca
2  signal. We propose that a specific Ca
2 -dependent
checkpoint is required for myofibrillogenesis. This signal is
not generated in the absence of calreticulin.
Early cardiogenesis is regulated by three families of tran-
scription factors (i.e., Nkx2.5, MEF2, GATA) (Srivastava
and Olson, 2000). Among these factors, MEF2C is an essen-
tial regulator of ventricular development (Black and Olson,
1998). The targeted disruption of the MEF2C gene in the
mouse results in embryonic lethality due to cardiac develop-
mental arrest and severe downregulation of a number of car-
diac markers (Durocher et al., 1996; Lin et al., 1997a; Char-
ron and Nemer, 1999) including MLC2v (Liu et al., 2001).
MEF2C is a major cardiac transcription factor regulating the
activity of MLC2v promoter (Chen et al., 1998; Nguyen-
Tran et al., 1999). Therefore, it is not surprising that im-
paired Ca
2 -dependent nuclear translocation of MEF2C in
crt
 /  cells results in low expression of MLC2v, and conse-
quently impaired myofibrillogenesis.
MEF2 is at the crossroad of multiple [Ca
2 ]c signals,
which affect transcriptional processes (Olson and Srivastava,
1996). Here we show that MEF2C function depends on the
presence of a calreticulin-dependent signal. MEF2 integrates
Ca
2 -dependent signals involving calcineurin, CaMKI,
CaMKIV, MKK6/p38 MAPK, and extracellular signal-regu-
lated kinase 5 (Yang et al., 1998; Blaeser et al., 2000; Friday
et al., 2000; Han and Molkentin, 2000; Passier et al., 2000).
Crt
 /  ES-derived cardiomyocytes have normal expression of
MEF2C, GATA4, or Nkx2.5, but have an impaired nuclear
translocation of MEF2C. MEF2C remains in the cytosol
and in perinuclear area in crt
 /  ES-derived cardiomyocytes,
whereas it is inside the nucleus in wt cells. This is specific for
MEF2C because nuclear localization of GATA4 is not af-
fected in crt
 /  cardiomyocytes. Indeed, GATA4 was cor-
rectly targeted to the nucleus of these cells. Therefore, our
data do not favor the hypothesis that the absence of calre-
ticulin, by affecting the Ca
2  filling state of the stores and
the nuclear cisternae, could indiscriminately impair the nu-
clear import of transcription factors through a conforma-
tional closure of nuclear pores after an upward shift of the
transporter (Perez-Terzic et al., 1996). How nuclear import
of macromolecules including MEF2C is impaired in crt
 / 
cardiomyocytes is currently under investigation.
As expected, MLC2a expression is significantly less affected
in crt
 /  cardiomyocytes, as it is likely activated by GATA4 and
Figure 6. Messenger RNA content and protein content of cardiac 
transcription factors in EBs. (A) Effect of ionomycin treatment on 
the mRNA level of MEF2C, Nkx2.5, and GATA4 during the EB 
differentiation. EBs were incubated at D4 followed by RNA isolation 
at D8. Levels of mRNA were measured using real-time quantitative 
PCR *, P   0.001. (B) Comparison of MEF2C protein expression in 
wt and crt
 /  EBs during cardiac cell differentiation, as assessed by 
Western blot analysis with the anti-MEF2C antibodies. 110 The Journal of Cell Biology | Volume 158, Number 1, 2002
Figure 7.  Study of the intracellular 
localization of MEF2C in clustered 
cardiomyocytes within EBs. (A) Three-
dimensional representation of MEF2C 
immunolocalization in cardiomyocytes 
within EBs at D8 of differentiation. (a to d) 
Shadow projections. (a  to d ) Profiles on 
the x–y dimension of MEF2C intranuclear 
localization visualized as the summed 
fluorescence distribution across the nuclei 
(fluorescence of middle plan crossing 
the nuclei in the z-axis). (a and a  and c 
and c ) wt EBs   ionomycin respectively. 
(b and b  and d and d ) crt
 /  EBs   
ionomycin. (a and b) wt and crt
 /  cells 
EB, respectively, in control conditions 
(addition of DMSO). (c and d) wt and 
crt
 /  cells treated with ionomycin, 
respectively. (Inset) Hoechst staining of 
nuclei within an EBs. (B) Profile on the 
x–y dimension of GATA4 intranuclear 
localization visualized as the summed 
fluorescence distribution across the nuclei 
(fluorescence of middle plan crossing 
the nuclei in the z-axis). Bars, 10  m 
(100 nuclei analyzed in four different 
experiments). Calreticulin and Ca
2  in cardiogenesis | Li et al. 111
Nkx2.5 factors (Gruber et al., 1998; Franco et al., 1999;
Nguyen-Tran et al., 1999; Doevendans et al., 2000). The pres-
ence of correctly inserted MLC2a is likely to account for some
contractility observed in 5–10% of crt
 /  EBs. This is in line
with calreticulin-knockout gene studies which showed that cal-
reticulin deficiency primarily affects ventricular development
and has no significant effect on atrial cells (Mesaeli et al., 1999).
Although inhibited nuclear translocation of MEF2C in
crt
 /  cardiomyocytes explains the reduced expression of
MLC2v, it cannot account for the lack of insertion of the ex-
isting light chains into functional sarcomeres. We show that
the latter defect is likely attributed to low active Ca
2 /cal-
modulin-dependent MLCK, which is required to phosphor-
ylate MLC2v prior to its assembly into sarcomeric units and
to ensure a normal Ca
2  sensitivity of myofilaments (Clem-
ent et al., 1992; Sanbe et al., 1999).
The most important finding of this study is that the cal-
reticulin-deficient phenotype can be rescued by increasing
[Ca
2 ]c in crt
 /  EBs. Treatment of EBs at D4 or D7 with
ionomycin restores the CaMK-dependent intranuclear local-
ization of MEF2C, MLC2v phosphorylation, its sarcomeric
insertion and contractility in crt
 /  EBs. In line with these
observations, inhibition of CaMK with KN93, chelation of
intracellular Ca
2  (BAPTA), or preventing Ca
2  influx in
EGTA-buffered extracellular medium abolishes nuclear lo-
calization of MEF2C in wt EBs. Thus, phosphorylation of
MEF2C by a cytosolic CaMK (Colomer and Means, 2000;
Olson and Williams, 2000; Corcoran and Means, 2001), is
required for its intranuclear targeting.
An elevation of [Ca
2 ]c by either a Ca
2  influx across the
plasma membrane and/or Ca
2  release from the ER is re-
quired to activate CaMKs, including MLCK to drive cardiac
myofibrillogenesis. In early cardiomyocytes differentiated
within EBs, the initiation of spontaneous contractions is
triggered by inositol 1,4,5-trisphosphate–dependent [Ca
2 ]c
oscillations from the ER and it does not require Ca
2 -
induced Ca
2  release from the sarcoplasmic reticulum (Vi-
atchenko-Karpinski et al., 1999). Crt
 /  cardiomyocytes do not
feature any spontaneous [Ca
2 ]c spikes, suggesting a defect
in inositol 1,4,5-trisphosphate signaling in calreticulin-defi-
cient cardiomyocytes. Although rapid [Ca
2 ]c signals induce
events such as muscle contraction, secretion, adhesion, and
and synaptic transmission, more sustained [Ca
2 ]c signals
are known to be involved in cell proliferation and differenti-
ation. We rescued the expression, the phosphorylation, and
the assembly of MLC2v into sarcomeric units by triggering a
transient but long-lasting [Ca
2 ]c increase in crt
 /  EBs be-
fore the appearance of contractions (i.e., D4 or D7) using
the Ca
2  ionophore, ionomycin. This treatment led to a re-
covery of contractility in crt
 /  ES-derived cardiomyocytes.
Although applied for a brief period (2 h), ionomycin in-
duced a transient but long-lasting Ca
2  influx into the em-
bryoid body as previously shown in other cell types (Tim-
merman et al., 1996; Durham and Russo, 2000). This
ionophore-dependent Ca
2  increase mimics receptor-medi-
ated Ca
2  elevation into the cytosol, an event missing in
crt
 /  EBs. It further resets the cardiac differentiation pro-
gram, paused after an early stage of cardiac commitment.
In summary, although crt
 /  cells seem to undergo a nor-
mal cardiac commitment up to D4 (time of maximal expres-
sion of cardiac transcription factors) (Meyer et al., 2000),
they have lost the ability to achieve the full differentiation
program, waiting for a Ca
2  signal. This is similar to a Ca
2 -
dependent block involving CaMKs activation as reported
during the development of Xenopus eggs (Lorca et al., 1993).
Thus, we provide evidence that a Ca
2 -dependent checkpoint
involving [Ca
2 ]c elevation in the cytoplasm and activation of
CaMKs is required at an early stage of differentiation to allow
cardiac precursors to fully differentiate into cardiomyocytes.
This Ca
2  checkpoint plays a dual role: it modulates Ca
2 -
dependent nuclear translocation of specific transcription fac-
tor, and it activates Ca
2 -dependent kinases (and phosphatases)
involved in early cardiac myofibrillogenensis.
Materials and methods
Embryonic stem cell culture and differentiation
wt or crt
 /  ES cells derived from J1 129/Sv mice were propagated on feeder
cells (mitomycin-treated mouse embryonic fibroblasts) using BHK21 me-
dium (GIBCO BRL) supplemented with pyruvate, nonessential amino acids,
mercaptoethanol, glutamine, 10% fetal calf serum (Biomedia) (Smith,
1992), and LIF-conditioned medium, obtained from preconfluent 740 LIF-D
cells, stably transfected with a plasmid encoding LIF (Meyer et al., 2000).
The cells were maintained at  70% confluency to keep an undifferenti-
ated phenotype. ES cells were differentiated in vitro as embryo-like aggre-
gates (EBs) using the hanging drop method (Maltsev et al., 1994). Briefly,
EBs were formed for 2 d (D0–D2) in hanging drops (450 cells/20 l) of dif-
ferentiation medium (BHK21, as described above), containing 20% fetal
calf serum and lacking of LIF. The EBs were then incubated in suspension
for 3 d (D2–D5) and transferred to gelatin-coated dishes or glass coverslips
(at D6). The differentiating EBs were examined daily under phase-contrast
microscopy for the presence of contracting cardiomyocytes.
Antibodies and immunocytochemistry
For immunostaining, EBs were fixed with 3% paraformaldehyde, perme-
abilized with 0.1% Triton X-100, and labeled with mouse monoclonal
anti-MEF2C (1/50) (Cell Signaling), anti- -actinin antibodies (1/500)
(Sigma-Aldrich), with rabbit anti-MLC2v (1/50), or anti-MLC2a (1/500) an-
tisera (Meyer et al., 2000). Secondary antibodies included rhodamine-con-
jugated goat anti–rabbit IgG and FITC-conjugated goat anti–mouse IgG
(Sigma-Aldrich) (dilutions 1/100) (Jaconi et al., 2000). Cell nuclei were vi-
sualized within the EBs by Hoechst staining.
Imaging of cytosolic calcium levels
EBs adherent on glass coverslips were loaded at D 4 or D8 with 5  M fluo3
or fluo4/AM (Molecular Probes) for 20 min, and transferred to the stage of an
epifluorescence microscope and perfused with a medium containing 20 mM
Hepes, 117 mM NaCl, 5.7 mM KCl, 1.2 mM NaH2PO4, 4.4 mM NaHCO3,
1.7 mM MgCl2, and 1.8 mM CaCl2, pH 7.4. The field was illuminated at
485   22 nm with a Xenon lamp. Fluo3 or fluo 4 emission fluorescence was
recorded through a dichroic mirror (cutoff 510 nm) and a long pass emission
filter (cutoff 520 nm) (Jaconi et al., 2000). The fluorescent images were re-
corded at 530 nm long pass filter, using a Nikon (diaphot) or Leica (DMRA)
microscope coupled to a CCD camera (micromax 1300Y/HS; Princeton) and
digitized on line by a computer (Metamorph software; Universal Imaging).
To calculate the frequency of [Ca
2 ]c spikes in embryoid bodies, a region of
interest was selected within a beating area and the average pixel intensity
was plotted as a function of time. To record long-term changes in [Ca
2 ]c in-
duced by ionomycin using time-lapse video microscopy (Metamorph soft-
ware), EBs were loaded with fluo4 prior to ionomycin application and re-
loaded 2 h later after washout of the ionophore. EBs were also reloaded with
fluo4 at the end of the time-lapse experiment to determine whether the low
levels of Ca
2  were due to a leakage of the probe. EBs were illuminated for 2 s,
and z-stacks of images were acquired every 15 min for up to 10 h.
All experiments were performed at 35   2 C, under 95%O2/5% CO2 at-
mosphere, and have been repeated on three separate occasions.
Cell imaging
Images of the adherent EBs were acquired with a 12-bit, cooled charge-cou-
pled device interlined camera (Visicam; Visitron System) mounted on a Nikon
Eclipse epifluorescence microscope, equipped with 40 , 63 , 100 , 1.3 NA
oil-immersion objectives. A monochromator coupled to an optic fiber (Delta-112 The Journal of Cell Biology | Volume 158, Number 1, 2002
Ram, Photon Technology International) allowed the excitation for the FITC
(488 nm, DM505, BA 520–560 nm) and the rhodamine (545 nm, DM575, BA
590) fluorescence respectively. Optical z-sectioning (0.2- m step) was
achieved using an objective-mounted piezo-electric controller (LVPDZ posi-
tion servo controller; Physik Instrumente) driven by the Metamorph 4.1 soft-
ware (Visitron; Universal Imaging). The stack of images, stored as volume files,
were processed by the software Huygens to perform digital restoration of the
images (Huygens 2.2.1; Scientific Volume Imaging) and visualized after three-
dimensional reconstruction using the Imaris software (Bitplane). All calcula-
tions were performed using an Octane workstation (Silicon Graphics).
RNA extraction and reverse transcription reaction
Total cellular RNA was isolated from EBs using the RNA Extraction Kit
(Perfect RNA Mini Kit; Eppendorf). Residual genomic DNA was removed
by incubating the RNA solution with 15 units of RNase-free DNase I
(CLONTECH Laboratories, Inc.) in 2 mM MgCl2 for 45 min at 37 C, fol-
lowed by inactivation at 90 C for 5 min. 1  g of DNase-treated RNA was
reverse transcribed using the Superscript II kit (GIBCO BRL). The cDNA
was diluted 10-fold prior to PCR amplification.
Real-Time quantitative PCR by SYBR green detection
The nucleotide sequences of the PCR primers used were: MEF2C for-
ward 5 -AGATACCCACAACACACCACGCGCC and reverse 5 -ATCCTTCA-
GAGAGTCGCATGCGCTT; GATA4 forward 5 -CGAGATGGGACGGGA-
CACT and reverse 5 -CTCACCCTCG-GCCATTACGA; and Nkx2.5 forward
5 -TGCAGAAGGCAGTGGAGCTGGACAAGCC and reverse 5 -TTGCACT-
TGTAGCGACGGTTCTGGAACCAG;   -tubulin forward 5 -CCGGACAGT-
GTGGCAACCAGATCGG and reverse 5 -TGGCCAAAAGGACCTGAGC-
GAACGG. Real-time quantitative PCR was performed using a LightCycler
rapid thermal cycler (Roche). Amplification was carried out as recommended
by the manufacturer. 12  l reaction mixture contained 1  l of LightCycler-
DNA Master SYBR Green I mix (FAST Start KIT, containing Taq DNA poly-
merase, reaction buffer, deoxynucleoside trisphosphate mix, and SYBR Green
I dye), 3 mM MgCl2, and 0.5  M concentration of appropriate primer and 2
 l of cDNA. The relative cDNA concentrations were established by a stan-
dard curve using sequential dilutions of corresponding PCR fragments. The
data were normalized by PCR analysis of the  -tubulin. The amplification
program included the initial denaturation step at 95 C for 8 min, and 40 cy-
cles of denaturation at 95 C for 3–5 s, annealing at 60–65 C for 6–10 s, and
extension at 72 C for 5–10 s. The temperature transition rate was 20 C/s. Fluo-
rescence was measured at the end of each extension step. After amplification,
a melting curve was acquired by heating the product at 20 C/s to 95 C, cool-
ing it at 20 C/s to 70 C, keeping it at 70 C for 20 s, and then slowly heating it
at 0.1 C/s to 95 C. Fluorescence was measured through the slow heating
phase. Melting curves were used to determine the specificity of PCR products,
which were further confirmed using conventional gel electrophoresis.
The Student’s t test was used to analyze statistical significance. All p
values corresponded to two-tailed tests, and a P of  0.05 was considered
statistically significant.
Western blotting analyses
The MLC2v and MEF2C proteins were identified by Western blot analysis
(Towbin et al., 1979; Clement et al., 1992). In brief, whole-cell lysate from
50 to 60 EBs was obtained using RIPA buffer (20 mM Tris-HCl, pH 7.8,
150 mM NaCl, 1% Triton X-100, 1% deoxycholic acid, 1mM EDTA,
0.05% SDS) supplemented with a protease inhibitors cocktail (Complete
TM
Mini; Boehringer Mannheim). Protein concentrations were determined by
BioRad protein assay. Proteins (50–70  g) were fractionated by SDS-
PAGE, electroblotted onto PVDF Immobilon-P transfer membrane (Milli-
pore), and probed with anti–MLC2v (dilution 1/500) or anti–MLC2a anti-
sera (1/5,000), or with anti–MEF2C antibody (dilution 1/1,000). Antibodies
were visualized by addition of HRP goat anti–rabbit IgG and enhanced
chemiluminescence reagents (ECL reagent; Amersham Biosciences).
Two-dimensional gel electrophoresis
wt or crt
 /  cell lysates from D8 EBs were prepared in a buffer containing (in
mM): NaCl 150, EDTA 1, Tris 20, Na3O4-vanadate 10, and NP-40 1%, pH
8.2. Only the Triton insoluble fraction containing the myofilaments was re-
suspended in O’Farell’s buffer (O’Farrel, 1975) before loading into the elec-
trofocalization capillaries. Unphosphorylated MLC2v was separated from the
phosphorylated protein by high-resolution two-dimensional gel electrophore-
sis (PAGE) as previously described (Hochstrasser et al., 1988; Gravel et al.,
1995). Nonlinear immobilized gradient strips (pH 3–10, NL IPG 18 cm; Am-
ersham Biosciences) were used as the first dimension. Hydration of gel strips
was performed by sample (100  g contractile proteins). Focusing started at
500 V for 2 h, and then the voltage was increased to 1,000 V for 2.5 h, to
3,000 V for 1 h, and subsequently it was gradually increased to 5,000 V (at
500 V/15 min) and kept constant overnight (total 24 h). Separation in the sec-
ond dimension was performed on 9–16% gradient polyacrylamide/pipera-
zine diacrylamide gels (30:0.8 proportion; BioRad Laboratories). The gels
(180   200   1.5 mm) were run in BioRad apparatus at 40 mA per gel, for
3–4 h. Subsequently, proteins were transferred on PVDF membranes (Amer-
sham Biosciences), and Western blot was performed as described above.
We are grateful to Dr. Pierre Travo (the Core Facility of Bitplane European
Advanced Imaging Center, CRBM, CNRS UPR1086, member of the European
Light Microscopy Initiative), for continuous support and skillful advice on im-
age restoration and analysis, Dr. Frederick Villhardt for his advice on two-
dimensional gel electrophoresis, and M. Oliver Plastre for technical help. 
This work was supported by grants from the Swiss National Science
Foundation (NRP-4046-058712 and 31-55344.98 to M. Jaconi and KH
Krause), Fondation de France (2000003470), and Association Française
contre les Myopathies (7778 to M. Pucéat), and from Canadian Institutes
for Health Research (to M. Michalak). We also gratefully acknowledge the
Region Languedoc-Roussillon, INSERM, and Association Française contre
le Cancer for their financial support for the acquisition of the light cycler
by the Institut Fédératif de Recherche Jean-François Pechère (IFR24) at
Montpellier. M. Pucéat is an established investigator of INSERM, and M.
Michalak is CIHR Senior Investigator and AHFMR Medical Scientist.
Submitted: 17 April 2002
Revised: 30 May 2002
Accepted: 30 May 2002
References
Aoki, H., J. Sadoshima, and S. Izumo. 2000. Myosin light chain kinase mediates sar-
comere organization during cardiac hypertrophy in vitro. Nat. Med. 6:183–188.
Bastianutto, C., E. Clementi, F. Codazzi, P. Podini, F. De Giorgi, R. Rizzuto, J.
Meldolesi, and T. Pozzan. 1995. Overexpression of calreticulin increases the
Ca
2  capacity of rapidly exchanging Ca
2  stores and reveals aspects of their
lumenal microenvironment and function. J. Cell Biol. 130:847–855.
Black, B.L., and E.N. Olson. 1998. Transcriptional control of muscle development
by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol.
14:167–196.
Blaeser, F., N. Ho, R. Prywes, and T.A. Chatila. 2000. Ca
2 -dependent gene expres-
sion mediated by MEF2 transcription factors. J. Biol. Chem. 275:197–209.
Bony, C., S. Roche, U. Shuichi, T. Sasaki, M.A. Crackower, J. Penninger, H. Mano,
and M. Puceat. 2001. A specific role of phosphatidylinositol 3-kinase  . A regu-
lation of autonomic Ca
2  oscillations in cardiac cells. J. Cell Biol. 152:717–728.
Burns, K., B. Duggan, E.A. Atkinson, K.S. Famulski, M. Nemer, R.C. Bleackley,
and M. Michalak. 1994. Modulation of gene expression by calreticulin
binding to the glucocorticoid receptor. Nature. 367:476–480.
Camacho, P., and J.D. Lechleiter. 1995. Calreticulin inhibits repetitive intracellu-
lar Ca
2  waves. Cell. 82:765–771.
Charron, F., and M. Nemer. 1999. GATA transcription factors and cardiac devel-
opment. Semin. Cell Dev. Biol. 10:85–91.
Chen, J., S.W. Kubalak, S. Minamisawa, R.L. Price, K.D. Becker, R. Hickey, J.
Ross, Jr., and K.R. Chien. 1998. Selective requirement of myosin light chain
2v in embryonic heart function. J. Biol. Chem. 273:1252–1256.
Clapham, D.E. 1995. Calcium signaling. Cell. 80:259–268.
Clement, O., M. Puceat, M.P. Walsh, and G. Vassort. 1992. Protein kinase C en-
hances myosin light-chain kinase effects on force development and ATPase
activity in rat single skinned cardiac cells. Biochem. J. 285:311–317.
Colomer, J.M., and A.R. Means. 2000. Chronic elevation of calmodulin in the
ventricles of transgenic mice increases the autonomous activity of calmodu-
lin-dependent protein kinase II, which regulates atrial natriuretic factor gene
expression. Mol. Endocrinol. 14:1125–1136.
Coppolino, M., C. Leung-Hagesteijn, S. Dedhar, and J. Wilkins. 1995. Inducible
interaction of integrin alpha 2 beta 1 with calreticulin. Dependence on the
activation state of the integrin. J. Biol. Chem. 270:23132–23138.
Coppolino, M.G., M.J. Woodside, N. Demaurex, S. Grinstein, R. St-Arnaud, and
S. Dedhar. 1997. Calreticulin is essential for integrin-mediated calcium sig-
nalling and cell adhesion. Nature. 386:843–847.
Corcoran, E.E., and A.R. Means. 2001. Defining Ca
2 /calmodulin-dependent protein
kinase cascades in transcriptional regulation. J. Biol. Chem. 276:2975–2978.
Dedhar, S., P.S. Rennie, M. Shago, C.Y. Hagesteijn, H. Yang, J. Filmus, R.G.
Hawley, N. Bruchovsky, H. Cheng, R.J. Matusik, et al. 1994. Inhibition of
nuclear hormone receptor activity by calreticulin. Nature. 367:480–483. Calreticulin and Ca
2  in cardiogenesis | Li et al. 113
Doevendans, P.A., R. Bronsaer, P.R. Lozano, S. Kubalak, and M. van Bilsen. 2000.
The murine atrial myosin light chain-2 gene: a member of an evolutionarily
conserved family of contractile proteins. Cytogenet. Cell Genet. 90:248–252.
Durham, P.L., and A.F. Russo. 2000. Differential regulation of mitogen-activated
protein kinase-responsive genes by the duration of a calcium signal. Mol. En-
docrinol. 14:1570–1582.
Durocher, D., C.Y. Chen, A. Ardati, R.J. Schwartz, and M. Nemer. 1996. The
atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the
myocardium. Mol. Cell. Biol. 16:4648–4655.
Ellgaard, L., and A. Helenius. 2001. ER quality control: towards an understanding
at the molecular level. Curr. Opin. Cell Biol. 13:431–437.
Fasolato, C., P. Pizzo, and T. Pozzan. 1998. Delayed activation of the store-oper-
ated calcium current induced by calreticulin overexpression in RBL-1 cells.
Mol. Biol. Cell. 9:1513–1522.
Franco, D., M.M. Markman, G.T. Wagenaar, J. Ya, W.H. Lamers, and A.F. Moor-
man. 1999. Myosin light chain 2a and 2v identifies the embryonic outflow
tract myocardium in the developing rodent heart. Anat. Rec. 254:135–146.
Frey, N., T.A. McKinsey, and E.N. Olson. 2000. Decoding calcium signals in-
volved in cardiac growth and function. Nat. Med. 6:1221–1227.
Friday, B.B., V. Horsley, and G.K. Pavlath. 2000. Calcineurin activity is required
for the initiation of skeletal muscle differentiation. J. Cell Biol. 149:657–666.
Gravel, P., J.C. Sanchez, C. Walzer, O. Golaz, D.F. Hochstrasser, L.P. Balant, G.J.
Hughes, J. Garcia-Sevilla, and J. Guimon. 1995. Human blood platelet pro-
tein map established by two-dimensional polyacrylamide gel electrophoresis.
Electrophoresis. 16:1152–1159.
Gruber, P.J., S.W. Kubalak, and K.R. Chien. 1998. Downregulation of atrial
markers during cardiac chamber morphogenesis is irreversible in murine em-
bryos. Development. 125:4427–4438.
Han, J., and J.D. Molkentin. 2000. Regulation of MEF2 by p38 MAPK and its
implication in cardiomyocyte biology. Trends Cardiovasc. Med. 10:19–22.
Harvey, R.P. 1999. Seeking a regulatory roadmap for heart morphogenesis. Semin.
Cell Dev. Biol. 10:99–107.
Harvey, R.P., and N. Rosental. 1999. Heart Development. Academic Press, San
Diego. 530 pp.
Helenius, A., E. Trombetta, D. Hebert, and J. Simons. 1997. Calnexin, calreticulin
and the folding of glycoproteins. Trends Cell Biol. 7:193–200.
Hochstrasser, D.F., M.G. Harrington, A.C. Hochstrasser, M.J. Miller, and C.R.
Merril. 1988. Methods for increasing the resolution of two-dimensional pro-
tein electrophoresis. Anal. Biochem. 173:424–435.
Jaconi, M., C. Bony, S.M. Richards, A. Terzic, S. Arnaudeau, G. Vassort, and M.
Puceat. 2000. Inositol 1,4,5-trisphosphate directs Ca
2  flow between mito-
chondria and the endoplasmic/sarcoplasmic reticulum: a role in regulating
cardiac autonomic Ca
2  spiking. Mol. Biol. Cell. 11:1845–1858.
John, L.M., J.D. Lechleiter, and P. Camacho. 1998. Differential modulation of
SERCA2 isoforms by calreticulin. J. Cell Biol. 142:963–973.
Krause, K.H., and M. Michalak. 1997. Calreticulin. Cell. 88:439–443.
Lin, Q., J. Schwarz, C. Bucana, and E.N. Olson. 1997a. Control of mouse cardiac
morphogenesis and myogenesis by transcription factor MEF2C. Science.
276:1404–1407.
Lin, Q., D. Srivastava, and E.N. Olson. 1997b. A transcriptional pathway for car-
diac development. Cold Spring Harb. Symp. Quant. Biol. 62:405–411.
Liu, N., R.E. Fine, E. Simons, and R.J. Johnson. 1994. Decreasing calreticulin ex-
pression lowers the Ca
2  response to bradykinin and increases sensitivity to
ionomycin in NG-108-15 cells. J. Biol. Chem. 269:28635–28639.
Liu, Z.P., O. Nakagawa, M. Nakagawa, H. Yanagisawa, R. Passier, J.A. Richard-
son, D. Srivastava, and E.N. Olson. 2001. Champ, a novel cardiac-specific
helicase regulated by mef2c. Dev. Biol. 234:497–509.
Lorca, T., F.H. Cruzalegui, D. Fesquet, J.C. Cavadore, J. Mery, A. Means, and M.
Doree. 1993. Calmodulin-dependent protein kinase II mediates inactivation
of MPF and CSF upon fertilization of Xenopus eggs. Nature. 366:270–273.
Maltsev, V.A., A.M. Wobus, J. Rohwedel, M. Bader, and J. Hescheler. 1994. Car-
diomyocytes differentiated in vitro from embryonic stem cells developmen-
tally express cardiac-specific genes and ionic currents. Circ. Res. 75:233–244.
Mery, L., N. Mesaeli, M. Michalak, M. Opas, D.P. Lew, and K.H. Krause. 1996.
Overexpression of calreticulin increases intracellular Ca
2  storage and de-
creases store-operated Ca
2  influx. J. Biol. Chem. 271:9332–9339.
Mesaeli, N., K. Nakamura, E. Zvaritch, P. Dickie, E. Dziak, K.H. Krause, M.
Opas, D.H. MacLennan, and M. Michalak. 1999. Calreticulin is essential
for cardiac development. J. Cell Biol. 144:857–868.
Meyer, N., M. Jaconi, A. Landopoulou, P. Fort, and M. Puceat. 2000. A fluores-
cent reporter gene as a marker for ventricular specification in ES-derived car-
diac cells. FEBS Lett. 478:151–158.
Michalak, M., E.F. Corbett, N. Mesaeli, K. Nakamura, and M. Opas. 1999. Cal-
reticulin: one protein, one gene, many functions. Biochem. J. 344:281–292.
Mitani, Y., G.R. Dubyak, and F. Ismail-Beigi. 1996. Induction of GLUT-1
mRNA in response to inhibition of oxidative phosphorylation: role of in-
creased [Ca
2 ]i. Am. J. Physiol. 270:C235–C242.
Nakamura, K., M. Robertson, G. Liu, P. Dickie, J.Q. Guo, H.J. Duff, M. Opas,
K. Kavanagh, and M. Michalak. 2001a. Complete heart block and sudden
death in mice overexpressing calreticulin. J. Clin. Invest. 107:1245–1253.
Nakamura, K., A. Zuppini, S. Arnaudeau, J. Lynch, I. Ahsan, R. Krause, S. Papp,
H. De Smedt, J.B. Parys, W. Müller-Esterl, et al. 2001b. Functional special-
ization of calreticulin domains. J. Biol. Chem. 154:961–972.
Nguyen-Tran, V.T.B., J. Chen, P. Ruiz-Lozano, and K.R. Chien. 1999. The
MLC-2 paradigm for ventricular heart chamber specification, maturation,
and morphogenesis. In Heart Development. R.P. Harvey and N. Rosental,
editors. Academic Press, San Diego. 55–272.
O’Farrel, P.H. 1975. high resolution two-dimensional electrophoresis of proteins.
J. Biol. Chem. 250:4007–4027.
Olson, E.N., and D. Srivastava. 1996. Molecular pathways controlling heart devel-
opment. Science. 272:671–676.
Olson, E.N., and R. Williams. 2000. Remodeling muscles with calcineurin. Bioes-
says. 22:510–519.
Opas, M., M. Szewczenko-Pawlikowski, G.K. Jass, N. Mesaeli, and M. Michalak.
1996. Calreticulin modulates cell adhesiveness via regulation of vinculin ex-
pression. J. Cell Biol. 135:1913–1923.
Passier, R., H. Zeng, N. Frey, F.J. Naya, R.L. Nicol, T.A. McKinsey, P. Overbeek,
J.A. Richardson, S.R. Grant, and E.N. Olson. 2000. CaM kinase signaling
induces cardiac hypertrophy and activates the MEF2 transcription factor in
vivo. J. Clin. Invest. 105:1395–1406.
Perez-Terzic, C., J. Pyle, M. Jaconi, L. Stehno-Bittel, and D.E. Clapham. 1996.
Conformational states of the nuclear pore complex induced by depletion of
nuclear Ca
2  stores. Science. 273:1875–1877.
Pozzan, T., R. Rizzuto, P. Volpe, and J. Meldolesi. 1994. Molecular and cellular
physiology of intracellular calcium stores. Physiol. Rev. 74:595–636.
Rauch, F., J. Prud’homme, A. Arabian, S. Dedhar, and R. St-Arnaud. 2000. Heart,
brain, and body wall defects in mice lacking calreticulin. Exp. Cell Res. 256:
105–111.
Sanbe, A., J.G. Fewell, J. Gulick, H. Osinska, J. Lorenz, D.G. Hall, L.A. Murray,
T.R. Kimball, S.A. Witt, and J. Robbins. 1999. Abnormal cardiac structure
and function in mice expressing nonphosphorylatable cardiac regulatory my-
osin light chain 2. J. Biol. Chem. 274:21085–21094.
Schwartz, R.J., and E.N. Olson. 1999. Building the heart piece by piece: modularity of
cis-elements regulating Nkx2-5 transcription. Development. 126:4187–4192.
Smith, A.G. 1992. Mouse embryo stem cells: their identification, propagation, and
manipulation. Semin. Cell Biol. 3:385–399.
Srivastava, D., and E.N. Olson. 2000. A genetic blueprint for cardiac development.
Nature. 407:221–226.
Sumi, M., K. Kiuchi, T. Ishikawa, A. Ishii, M. Hagiwara, T. Nagatsu, and H.
Hidaka. 1991. The newly synthesized selective Ca
2 /calmodulin dependent
protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h
cells. Biochem. Biophys. Res. Commun. 181:968–975.
Timmerman, L.A., N.A. Clipstone, S.N. Ho, J.P. Northrop, and G.R. Crabtree.
1996. Rapid shuttling of NF-AT in discrimination of Ca
2  signals and im-
munosuppression. Nature. 383:837–840.
Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of pro-
teins from polyacrylamide gels to nitrocellulose sheets: procedure and some
applications. Proc. Natl. Acad. Sci. USA. 76:4350–4354.
Viatchenko-Karpinski, S., B.K. Fleischmann, Q. Liu, H. Sauer, O. Gryshchenko,
G.J. Ji, and J. Hescheler. 1999. Intracellular Ca
2  oscillations drive sponta-
neous contractions in cardiomyocytes during early development. Proc. Natl.
Acad. Sci. USA. 96:8259–8264.
Yang, C.C., O.I. Ornatsky, J.C. McDermott, T.F. Cruz, and C.A. Prody. 1998.
Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated
protein kinase, ERK5/BMK1. Nucleic Acids Res. 26:4771–4777.
Zhang, T., E.N. Johnson, Y. Gu, M.R. Morissette, V.P. Sah, M.S. Gigena, D.D. Belke,
W.H. Dillmann, T.B. Rogers, H. Schulman, Jr., J. Ross, and J.H. Brown. 2002.
The cardiac-specific nuclear delta(B) isoform of Ca
2 /calmodulin-dependent
protein kinase II induces hypertrophy and dilated cardiomyopathy associated
with increased protein phosphatase 2A activity. J. Biol. Chem. 277:1261–1267.
Zou, Y., and K.R. Chien. 1995. EFIA/YB-1 is a component of cardiac HF-1A
binding activity and positively regulates transcription of the myosin light-
chain 2v gene. Mol. Cell. Biol. 15:2972–2982.